Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

Trial Identifier:	MEQ00076
Sponsor:	Sanofi
Start Date:	September 2025
Primary Completion Date:	June 2026
Study Completion Date:	November 2026
Condition:	Immune, Inflammatory & Infections - Other; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CHINA, Guangxi	Nanning, Guangxi, CHINA, 530028

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.